GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SMS Pharmaceuticals Ltd (BOM:532815) » Definitions » Cyclically Adjusted Revenue per Share

SMS Pharmaceuticals (BOM:532815) Cyclically Adjusted Revenue per Share : ₹86.34 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is SMS Pharmaceuticals Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

SMS Pharmaceuticals's adjusted revenue per share for the three months ended in Dec. 2024 was ₹20.432. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹86.34 for the trailing ten years ended in Dec. 2024.

During the past 12 months, SMS Pharmaceuticals's average Cyclically Adjusted Revenue Growth Rate was 5.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of SMS Pharmaceuticals was 6.40% per year. The lowest was 6.40% per year. And the median was 6.40% per year.

As of today (2025-05-17), SMS Pharmaceuticals's current stock price is ₹259.30. SMS Pharmaceuticals's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2024 was ₹86.34. SMS Pharmaceuticals's Cyclically Adjusted PS Ratio of today is 3.00.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of SMS Pharmaceuticals was 4.29. The lowest was 0.75. And the median was 1.75.


SMS Pharmaceuticals Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for SMS Pharmaceuticals's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMS Pharmaceuticals Cyclically Adjusted Revenue per Share Chart

SMS Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 69.97 72.43 76.86 84.20

SMS Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.25 84.20 86.06 86.91 86.34

Competitive Comparison of SMS Pharmaceuticals's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, SMS Pharmaceuticals's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SMS Pharmaceuticals's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SMS Pharmaceuticals's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where SMS Pharmaceuticals's Cyclically Adjusted PS Ratio falls into.


;
;

SMS Pharmaceuticals Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SMS Pharmaceuticals's adjusted Revenue per Share data for the three months ended in Dec. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=20.432/158.3229*158.3229
=20.432

Current CPI (Dec. 2024) = 158.3229.

SMS Pharmaceuticals Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 19.217 91.425 33.279
201406 16.274 94.103 27.380
201409 15.954 96.780 26.099
201412 17.529 96.780 28.676
201503 18.693 97.163 30.459
201506 14.638 99.841 23.212
201509 18.057 101.753 28.096
201512 18.332 102.901 28.206
201603 20.225 102.518 31.234
201606 17.210 105.961 25.715
201609 21.117 105.961 31.552
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 14.833 111.317 21.097
201809 15.954 115.142 21.937
201812 11.934 115.142 16.410
201903 11.858 118.202 15.883
201906 13.873 120.880 18.170
201909 13.955 123.175 17.937
201912 9.505 126.235 11.921
202003 10.904 124.705 13.843
202006 13.335 127.000 16.624
202009 15.422 130.118 18.765
202012 17.605 130.889 21.295
202103 19.996 131.771 24.025
202106 19.248 134.084 22.728
202109 20.636 135.847 24.050
202112 14.476 138.161 16.589
202203 6.631 138.822 7.562
202206 7.615 142.347 8.470
202209 19.052 144.661 20.851
202212 17.393 145.763 18.892
202303 17.323 146.865 18.675
202306 15.937 150.280 16.790
202309 19.755 151.492 20.646
202312 19.130 152.924 19.805
202403 28.813 153.035 29.809
202406 19.459 155.789 19.776
202409 23.304 157.882 23.369
202412 20.432 158.323 20.432

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


SMS Pharmaceuticals  (BOM:532815) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

SMS Pharmaceuticals's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=259.30/86.34
=3.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of SMS Pharmaceuticals was 4.29. The lowest was 0.75. And the median was 1.75.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


SMS Pharmaceuticals Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of SMS Pharmaceuticals's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


SMS Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
Plot No. 72, H.No. 8-2-334/3&4, Road. No. 5, Opposite SBI Executive Enclave, Banjara Hills, Hyderabad, TG, IND, 500034
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the manufacturing and sale of active pharmaceutical ingredients (API's), and their intermediates viz. Metal Acetylacetonates, Diltiazem Hydrochloride and Taxol C-13 Side Chain. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, among others.

SMS Pharmaceuticals Headlines

No Headlines